Chemomab Therapeutics Ltd. (CMMB)
2.59
-0.10
(-3.72%)
USD |
NASDAQ |
Sep 10, 16:00
2.59
0.00 (0.00%)
After-Hours: 20:00
Chemomab Therapeutics Total Liabilities (Quarterly) : 1.553M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.553M |
| March 31, 2026 | 1.113M |
| December 31, 2025 | 1.478M |
| September 30, 2025 | 1.137M |
| June 30, 2025 | 1.43M |
| March 31, 2025 | 2.426M |
| December 31, 2024 | 3.427M |
| September 30, 2024 | 4.579M |
| June 30, 2024 | 4.559M |
| March 31, 2024 | 4.678M |
| December 31, 2023 | 5.154M |
| September 30, 2023 | 5.375M |
| June 30, 2023 | 6.858M |
| March 31, 2023 | 7.059M |
| December 31, 2022 | 6.840M |
| September 30, 2022 | 5.595M |
| June 30, 2022 | 4.542M |
| March 31, 2022 | 3.72M |
| December 31, 2021 | 2.887M |
| September 30, 2021 | 1.928M |
| June 30, 2021 | 2.479M |
| March 31, 2021 | 4.959M |
| December 31, 2020 | 2.602M |
| September 30, 2020 | 2.338M |
| June 30, 2020 | 1.859M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.623M |
| December 31, 2019 | 4.846M |
| September 30, 2019 | 21.57M |
| June 30, 2019 | 6.173M |
| March 31, 2019 | 10.43M |
| December 31, 2018 | 13.66M |
| September 30, 2018 | 14.97M |
| June 30, 2018 | 18.73M |
| March 31, 2018 | 5.648M |
| December 31, 2017 | 2.696M |
| September 30, 2017 | 2.883M |
| June 30, 2017 | 2.740M |
| March 31, 2017 | 3.149M |
| December 31, 2016 | 2.356M |
| September 30, 2016 | 1.969M |
| June 30, 2016 | 1.231M |
| March 31, 2016 | 0.9222M |
| December 31, 2015 | 1.371M |
| September 30, 2015 | 1.519M |
| June 30, 2015 | 1.838M |
| March 31, 2015 | 1.481M |
| December 31, 2014 | 1.215M |
| September 30, 2014 | 2.111M |
| June 30, 2014 | 1.593M |
| March 31, 2014 | 1.517M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioLineRx Ltd. | 16.86M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 113.60M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 5.545M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.24M |
| Shareholders Equity (Quarterly) | 8.685M |
| Current Ratio | 6.411 |
| Net Debt Paydown Yield | 0.50% |